Q1 2023 Iovance Biotherapeutics Inc Earnings Call Transcript
Hello, and thank you for standing by. My name is Andrew and I will be your conference operator today. At this time, I would like to welcome everyone to the Iovance Biotherapeutics First Quarter 2023 Financial Results Conference Call. (Operator Instructions)
It is now my pleasure to introduce Senior Vice President, Investor Relations and Corporate Communications, Sara Pellegrino.
Thank you, operator. Good afternoon and thank you for joining us. Speaking on today's call, we have Dr. Fred Vogt, our Interim President and Chief Executive Officer; Dr. Igor Bilinsky, our Chief Operating Officer; Jim Ziegler, our Executive Vice President, Commercial; Dr. Friedrich Finckenstein, our Chief Medical Officer; and Jean-Marc Bellemin, our Chief Financial Officer; Dr. Raj Puri, our Executive Vice President, Regulatory Strategy and Translational Medicine is available for Q&A session.
This afternoon, we issued a press release that can be found on our corporate website at
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |